IMBeacon Healthcare

Device adoption, drug pipelines, and population health, drawn from CMS claims, FDA filings, and public-health data. Built for MedTech, pharma, and public-health teams who need the clinical evidence and regulatory filings behind a market, not just the press release. It's an input for clinical and regulatory experts, not a regulatory, clinical, or promotional document.

Three ways into healthcare research

Each covers a different angle on the industry. Open one to see its full set of workflows.

Healthcare Device Market
Where a device category stands today, market sizing, competitive intensity, pricing by pathology, and adoption by geography and end-user, drawn from FDA filings and claims data, not a market research summary.
MedTech strategy, device makers & regulatory affairs
Molecule Market
How a therapeutic area is developing, from active ingredient and formulation to approval pipeline and market pricing, drawn from FDA actions and market data, not a market research summary.
Pharma commercial, market-access & policy teams
Public Health
Disease burden, risk behaviors, and how well interventions are actually reaching people, drawn from real national health data.
Public-health agencies, NGOs & epidemiologists
Our Workflow

Traceable claims, molecules, and adoption barriers

CMS, FDA, and CDC records are gathered, filtered to what bears on the question, then modeled against what stands in the way.

Trial evidence is filtered
Trials, approvals, and reimbursement records bearing on the question are filtered out and structured for review.
Claims and filings collection
CMS claims, FDA submissions, and CDC datasets are gathered into a single evidence base through deep research.
Adoption and pricing are modeled
Adoption, pricing, and regulatory signals are modeled against the opportunity and what stands in its way.
Figures stay tied to filings
Each number is traced back to the claim, filing, or dataset behind it, so nothing goes unsupported.
FAQ

Questions Healthcare teams ask

Provenance, privacy, and what our research can and cannot be used for.

CMS claims, FDA submissions, and CDC datasets are pulled on their own publication schedules, so a report reflects the latest release available rather than a fixed snapshot. Each figure carries the date of the source it came from.

Every figure in a research output links back to the filing, claim, or dataset behind it. Every agent grounds each claim with a traceable citation, so the primary source can be checked before it reaches a committee or a regulator.

No. The research summarizes public evidence and clearly separates what a source states from what the analysis infers. It is an input for clinical and regulatory experts, not a regulatory, clinical, or promotional document.

Workflows are templates, not fixed lists. Each one runs against the pathology, device class, therapeutic area, or geography it is pointed at, including niche categories with thin published coverage.

Yes. Workflows run standalone or chain together, so a single brief can cover device adoption, competing drug pipelines, and the population trend driving demand.

Divergent trial outcomes and claims data are presented against each other with the source and date behind each, rather than reconciled into one figure. Where evidence is absent, the gap is stated rather than inferred.

Other Verticals

Explore other use case categories

Healthcare is one of five ways into IMBeacon.ai. See how other teams put it to work.
Financial & Business

Business research, company deep dives, sector reports, and commodity analysis — for analysts, founders, and strategy teams who need the full picture before they decide.

Learn More
Academia & Research

Literature reviews, background orientation, and methodology checks — for researchers and students building on a sound evidence base.

Learn More

Start Researching Smarter

Be among the first to use IMBeacon.ai
and cut research time in half.